Bristol Myers Squibb Provides Update on CheckMate -914 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as Adjuvant Treatment of Localized Renal Cell Carcinoma

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that Part A of the Phase 3 CheckMate -914 trial, evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) as an adjuvant treatment for patients with localized renal cell carcinoma (RCC) who have undergone full or partial removal of the kidney and who are at moderate or high risk … [Read more…]

Colgate Announces 2nd Quarter 2022 Results

NEW YORK–(BUSINESS WIRE)–Colgate-Palmolive Company (NYSE:CL): Net sales increased 5.5%; Organic sales* increased 9.0% with growth in every division and all four categories GAAP EPS declined 13% to $0.72; Base Business EPS* declined 10% to $0.72 GAAP Gross profit margin and Base Business Gross profit margin* both decreased 300 basis points to 57.0% Net cash provided … [Read more…]

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

Second Sight to change its name to Vivani Medical, Inc. LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July … [Read more…]

Global Mesenchymal Stem Cells Market Intelligence Report 2022: Featuring Key Players Merck, Genlantis, Cell Applications & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Mesenchymal Stem Cells Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Mesenchymal Stem Cells Market is projected to reach USD 5,847.88 million by 2027 from USD 2,731.51 million in 2021, at a CAGR 13.52% during the forecast period. Market Statistics: The Americas Mesenchymal Stem … [Read more…]

Global Upper Extremity Prosthetics Pipeline Report 2022 Update – by Stages of Development, Segments, Region, Regulatory Path and Key Companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Upper Extremity Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The publisher’s Medical Devices sector report, Upper Extremity Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update … [Read more…]

Global Liver Disease Diagnostics Market Research Report to 2027 – Featuring Abbott Laboratories, AstraZeneca, Bayer and bioMerieux Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Liver Disease Diagnostics Market Research Report by Diagnosis Technique (Biopsy, Endoscopy, and Imaging), End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Liver Disease Diagnostics Market size was estimated at USD 158.91 million … [Read more…]

The Worldwide Telepsychiatry Industry is Expected to Reach $9.7 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Telepsychiatry Market Research Report by Product (Crisis solutions, Forensic solutions, and In-home solutions), Age group, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Telepsychiatry Market size was estimated at USD 4,398.22 million … [Read more…]

XRAI Glass: Revolutionary New Glasses Allow Deaf People and People Who Have Hearing Loss to ‘See’ Conversations

LONDON–(BUSINESS WIRE)–Today, XRAI Glass announces the launch of the public preview of its revolutionary technology. XRAI Glass is a pioneering software product with a mission to enrich conversation for hundreds of millions of people1 around the world who are deaf or have hearing loss. Users wearing phone-tethered augmented reality (AR) smart glasses will be able … [Read more…]

Vitamin D VITAL for Health—Study, Editorial a Disservice to Americans Seeking Better Health, According to CRN

WASHINGTON–(BUSINESS WIRE)–#bonehealth–The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today responded to the results of an ancillary study of the Vitamin D and Omega-3 Trial (VITAL) reported today in the New England Journal of Medicine. Statement by Andrea Wong, Ph.D., CRN senior vice president scientific … [Read more…]

Cutera, Inc. to Announce Second Quarter Results on August 4, 2022

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the second quarter after the market close on Thursday, August 4, 2022. The Company’s management will host a conference call to discuss these results and related matters at … [Read more…]